Amy Steinkellner, PharmD, Senior Consultant

Amy Steinkellner, PharmD, has worked with the Real Endpoints team since 2012. She serves as senior clinical consultant to the research and strategic development of the RxScorecard, providing oversight for the clinical credibility and evidence basis of drug evaluation activities, and bringing unique insight on the US payer perspective with respect to the economic and clinical aspects of value in pharmacy.

Dr. Steinkellner has over 15 years of experience in the pharmacy benefit management (PBM) industry. She spent the majority of her PBM career with Medco Health Solutions, Inc. (now Express Scripts, Inc.) where she most recently was Vice President and National Practice Leader for the Women’s Health Therapeutic Resource Center. This role included development of clinical quality improvement goals for a pharmacy service model that was focused on the unique clinical needs and service expectations of women. She also served as Vice President of Clinical Programs and Services for Medco’s System Division, which comprised over 600 payer clients and $4B in drug spend from across small and mid-size employers, TPAs and Regional Health Plans.

Dr. Steinkellner holds a Doctor of Pharmacy from Mercer University and completed a residency in drug policy and clinical economics at the University of Wisconsin.

Our Team

Jeffrey Berkowitz

CEO and Director

Mr. Berkowitz is one of the rare top executives whose career has spanned most key verticals in global healthcare -- with executive committee and....

read full biography >

Susan Raiola

President

Susan Raiola is the President of Real Endpoints. Ms. Raiola has over 10 years of experience in the pharmaceutical consulting...

read full biography >

Roger Longman

Chairman

Mr. Longman is recognized as an expert in biopharmaceutical strategy and reimbursement and often speaks at key...

read full biography >

Norman Selby

Vice Chairman

Norman C. Selby has spent 35 years in the healthcare world in a variety of consulting, managerial, investor and Board roles...

read full biography >

Jane F. Barlow, MD, MPH, MBA

EVP & Chief Clinical Officer

Jane Barlow is a clinical and strategic executive with over 25 years of healthcare leadership...

read full biography >

Beth Nash, MD

Chief Medical Officer

Dr. Beth Nash is Chief Medical Officer at Real Endpoints, where her team of pharmacists and biostatisticians has developed...

read full biography >

Laura Farmer

SVP, Business Development and Marketing

Laura Farmer leads business development and marketing for Real Endpoints and subsidiary, Reimbursement Intelligence...

read full biography >

Heather Ritchie

VP, Product Strategy and Development

Heather Ritchie is VP Product Strategy and Development at Real Endpoints. She works closely with our customers and partners...

read full biography >

Jane Borne, RPh

VP, Pharmacy

Jane Borne, RPh, is responsible for ensuring the clinical credibility and evidence basis of all RE drug evaluation activities...

read full biography >

Amy Steinkellner, PharmD

Senior Consultant

Amy Steinkellner, PharmD, has worked with the Real Endpoint team since 2012. She serves as senior clinical advisor to the research...

read full biography >

Robert Galvin, MD

Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH), which oversees the management of health care for firms...

read full biography >

Michael Sherman, MD

Dr. Michael Sherman serves as Chief Medical Officer and senior vice president for Harvard Pilgrim Health Care...

read full biography >

Dennis Purcell

Dennis is the Founder, Senior Advisor, and previous Senior Managing Partner of Aisling Capital LLC.,  a leading investment firm...

read full biography >

Linda Blackerby

Linda has been serving as the President of Pharma Intelligence at Informa since May 2015, overseeing an income statement...

read full biography >

Arthur Pappas (Observer)

Art has over 30 years of experience as a pharmaceutical industry executive and venture capital investor in...

read full biography >